- Category
- Micro (2021-22)
- Udyam number
- UDYAM-DL-11-0021145

About Well Rise Pharma Private Limited
Data last updated:
Well Rise Pharma Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 September 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2021PTC386218. Its GSTIN is 07AADCW0499B1ZE (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Swapan Kumar Roy and Mohit Bharti.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at E – 17 G/F Qutub Vihar Phase – I Behind Mcd School, Delhi, India – 110071.
As per the financials filed for FY 2024, the company reported a revenue of ₹67.15 Lakh, a growth of 55% compared to the previous year. For the same year it recorded a net loss of ₹2.1 Lakh (net margin -3.1%) and EBITDA of -₹1.95 Lakh (EBITDA margin -2.9%).
Well Rise Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0021145). For more details, the company can be reached via its website wellrisepharma.com.
Company details
Recognitions & Rankings of Well Rise Pharma
Contact details
Well Rise Pharma Private Limited's registered office is in Delhi, Delhi.
- Registered AddressE – 17 G/F Qutub Vihar Phase – I Behind Mcd School, Delhi, India – 110071
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Well Rise Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Well Rise Pharma Private Limited, buy the company report.
Financials of Well Rise Pharma Private Limited
FY 2024 filings availableWell Rise Pharma Private Limited reported revenue of ₹67.15 Lakh (up 55% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 55% in the latest year. EBITDA fell 395% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹1.95 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹2.1 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -2.9% | ||
| Net Profit Margin | -3.1% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Well Rise Pharma Private Limited, buy the company report.
Board of directors of Well Rise Pharma Private Limited
Well Rise Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Swapan Kumar Roy | Director | 21 Apr 2022 | 4 Years 6 Months | Current |
| Mohit Bharti | Director | 07 Sep 2021 | 5 Years 2 Months | Current |
Peer comparison
Well Rise Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medox Remedies Private Limited | ₹67.35 Lakh (FY 2022) | 30.0% | New Delhi, Delhi, India | |||
| Oricare Pharma Private Limited | ₹67.23 Lakh (FY 2023) | 0.0% | Ahmedabad, Gujarat, India | |||
| Well Rise Pharma Private Limitedthis company | ₹67.15 Lakh (FY 2024) | -₹2.1 Lakh | -3.1% | 55.0% | Delhi, India | |
| Sriramchem Laboratories Private Limited | ₹67.12 Lakh (FY 2024) | 16.0% | Mysore, Karnataka, India | |||
| Astronix Healthcare Private Limited | ₹67.07 Lakh (FY 2019) | Kolkata, West Bengal, India |
To see the full peer comparison of Well Rise Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Well Rise Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Well Rise Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Well Rise Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AADCW0499B1ZE | Delhi | Active | 25 Sep 2021 |
To see the full GST registrations and return filing status of Well Rise Pharma Private Limited, buy the company report.
Recent activity
Well Rise Pharma Private Limited has 5 board changes on record since 2021: 2 appointments and 3 cessations. The latest: Mahmood Alam ceased to be Additional Director on 07 Sep 2023.
Frequently asked questions
Well Rise Pharma is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 September 2021 (5+ years old) and is registered under CIN U24232DL2021PTC386218.
Well Rise Pharma has 2 current directors:
- Swapan Kumar Roy - Director
- Mohit Bharti - Director
The latest financial statements of Well Rise Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Well Rise Pharma is 07AADCW0499B1ZE, registered in Delhi.
The CIN (Corporate Identification Number) of Well Rise Pharma is U24232DL2021PTC386218. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Well Rise Pharma was incorporated on 07 September 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Well Rise Pharma by revenue are Medox Remedies Private Limited, Oricare Pharma Private Limited, Sriramchem Laboratories Private Limited, Astronix Healthcare Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Mahmood Alam ceased to be Additional Director on 07 Sep 2023. Roop Kumar ceased to be Director on 07 Sep 2023. Swapan Kumar Roy ceased to be Director on 14 Nov 2022. Well Rise Pharma has 5 board changes on record in total.
Yes, Well Rise Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-11-0021145).
Well Rise Pharma can be reached through the website wellrisepharma.com. Its registered office is in Delhi, India.
The registered office of Well Rise Pharma is at E – 17 GF Qutub Vihar Phase – I Behind Mcd School, Delhi, India – 110071.

